(CercleFinance.com) – Predilife announces the signing of a collaboration with Hôpitaux du Léman, an establishment of the Groupement Hospitalier Léman-Mont-Blanc, with the launch of a study to deploy breast cancer prevention assessment in clinical practice .
The Hôpitaux du Léman, supported by the Association Seins Léman Avenir, are thus the first public institution to engage in a breast cancer prevention approach by opening a risk consultation using the Mammorisk test.
This predictive test allows the doctor to assess, in women from the age of 40, the probability of developing invasive breast cancer within five years, and to offer them a screening and follow-up program adapted to their individual risk.